Folate - galactose - targeted delivery of fluoresceine isothiocyanate as a drug model prepared by Fol-Peg-G-Pei-Gal conjugate as a novel carrier

International Journal of Pharmaceutical Research

Volumn 3, Issue 2, 2011, Pages 20-26

  Ghiamkazemi, S ^a,b   Hajiabedin, M ^e   Amanzadeh, A ^d   Amini, T ^f   Dinarvand, R ^a,b   Amini, M ^b,c   Rafiee Tehrani, M ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d PASTEUR INSTITUTE OF IRAN   (Iran)

^e ISLAMIC AZAD UNIVERSITY   (Iran)

^f Nobleceuticals Ltd   (United Kingdom)

Author keywords

Fluoresceine isothiocyanate; FOL PEG g PEI GAL; HEK293 and KB and HepG2 cell lines; Pegylation; Polyethylenimine; Targeted drug delivery

Indexed keywords

COPOLYMER; FLUORESCEIN ISOTHIOCYANATE; FOLIC ACID; GALACTOSE; GREEN FLUORESCENT PROTEIN; LACTOBIONIC ACID; MACROGOL; POLYETHYLENEIMINE;

ARTICLE; CELL STRAIN HEK293; CELL STRAIN HEPG2; CELL STRAIN KB; CELL VIABILITY; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; COVALENT BOND; CYTOTOXICITY TEST; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; EMBRYO; HUMAN; HUMAN CELL; HYDROPHILICITY; INTRACELLULAR SIGNALING; LIGAND BINDING; MOLECULAR STABILITY; MOLECULAR WEIGHT; PROTON NUCLEAR MAGNETIC RESONANCE; TARGET CELL; ZETA POTENTIAL;

EID: 79960113416     PISSN: None     EISSN: 09752366     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Woffendin C, Ranga Z, Wu L. Expression of a protective gene prolongs survival of T cells in human immunodeficiency virus-infected patients. Proc.Natl. Acad. Sci. U.S.A. 1996; 93: 2889-2894.
2. Hammond S. M, Caudy A. A, Hannon G.J. Post- transcriptional gene silencing by double strand RNA. Nat.Rev.Genet (2001); 2: 110-119.
3. Gin J.N. Genetic, cellular and immune approaches to disease therapy: past and future, Nat. Med, 2004; 10:135-141.
4. Sadeghi A.M.M, Amini M, Avadi M.R, Rafiee-Tehrani M, Junginger H.E. Synthesis, Characterization and Antibacterial effects of trimethylated and triethylated 6-NH2-6-Deoxy Chitosan, J.Bioactive and Compatible Polymer 2008; 23: 262-275.
5. Duan Y, Zheng J, Han S.A tumor targeted gene vector modified with G250 monoclonal antibody for gene therapy. J.Controlled.Release 2008;127: 173-179.
6. Park M.R, Han K.O, Han I. K Degradable Polyethylenimine-alt- Poly (ethylene glycol) copolymers as novel gene carriers, J. Controlled. Release 2005; 105: 367-380.
7. Park T.G, kim S.W, Jeong J.H. Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified Poly (ethylenimine), J. Controlled. Release 2005; 104: 223-232.
8. Jin T, Zhang Z, Chen M. Novel Poly (ethylenimine) biscarbamate conjugates as an efficient and nontoxic gene delivery system. J.Controlled.Release 2008; 130: 64-68.
9. Kim E.M., Jeong H.J, Moon M.H. Asialoglycoprotein receptor targeted gene delivery using galactosylated Polyethylenimine- graft -Poly (ethylene glycol): In vitro and in vivo studies. J.Controlled.Release 2005; 108: 557-567.
10. Cho C.S, Park I.K, Cho C.S. Galactosylated Poly (ethylene glycol)-Chitosan - graft- Polyethylenimine as a gene carrier for hepatocyte-targetimg. J. Controlled.Release 2008; 131:150-157.
11. Kim S.W, Bae Y.H, Ahn C.H. Biodegradable Poly (ethylenimine) for plasmid DNA delivery. J. Controlled. Release 2002; 80: 273-282.
12. Amiji M, Kommareddy S. Prepration and evaluation of Thiol-Modified Gelatin nanoparticles for intracellular DNA delivery in response to Glutathione. Bioconjugate Chem 2005; 16:1423-1432.
13. Kaul G, Amiji M. Cellular interaction and in vitro DNA transfection studies with Poly(ethylene glycol)-modified gelatin nanoparticles. J. Pharm. Sci 2004; 94:184-198.
14. Jiang H.L, Kim Y.K, Cho C.S. Chitosan-graft-Polyethylenimine as a gene carrier. J.Control.Release 2007; 117: 273-280.
15. Kunnath K, Harpe A, Fischer D, Bickel U. Lowmolecular-weight Polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight Polyethylenimine. J. Controlled. Release 2003; 89:113-125.
16. Davaran S, Omidi Y, anzabi M, davaran F. Preparation and in vitro evaluation of linear and star-branched PLGA nanoparticles for Insulin delivery. J. Bioactive and Compatible Polymer 2008; 23:115-131.
17. Joung Y.K, Bae J.W, Park K.D. An In situ gel-forming Heparin conjugated PLGA-PEG-PLGA copolymer, J. Bioactive and Compatible Polymer.2008; 23: 444-457.